Methods: On 3rd June 2016 Embase and PubMed databases were systematically searched for all relevant articles on prevalence of pathogenic submicroscopic CNVs in fetuses tested due to advanced maternal age or parental anxiety. Relevant full text articles were analysed and based on the extracted data the prevalence of submicroscopic CNVs was calculated. Results: Meta-analysis was conducted in a pooled cohort of 10,614 fetuses based on the 10 largest studies (N > 300) of a total of 19 relevant studies. In 0.84%, 95%CI [0.55%, 1.30%] of fetuses a submicroscopic pathogenic aberration was detected prenatally. The onset/penetrance of the submicroscopic findings was studied in 10,314 fetuses out of 8 papers that presented aberrant cases with all necessary details. The prevalence of early onset syndromic disorders due to a submicroscopic aberration was calculated to be 1:270, based on 0.37%, 95%CI [0.27%, 0.52%] cases where aberrations were specified.
Objectives: Prenatal diagnostics has been impacted by technological changes in the past decade, which have affected the diagnostic yield. The aim of this study was to evaluate the impact of SNP array and non-invasive prenatal testing (NIPT) on the diagnostic yield and the number of invasive tests in our centre. Methods: The frequency of pathogenic fetal unbalanced chromosome aberrations was studied in 6811 high risk pregnancies without ultrasound anomalies referred for prenatal testing in 2009-2015 due to advanced maternal age, abnormal first trimester screening results (with nuchal translucency < 3.5mm) or recurrence risk for chromosome aberration. Chromosomal SNP microarray analysis replaced karyotyping in 2012 and since 2014 a choice between NIPT and diagnostic testing with microarray was offered to women with an increased risk for common aneuploidy (as a part of a national TRIDENT study). Results: The introduction of microarray led to an additional yield of submicroscopic pathogenic chromosome aberrations in 1.9% in fetuses without ultrasound anomalies. The introduction of NIPT led to a decrease of invasive tests, but also of the diagnostic yield. Conclusions: Since 33% of pathogenic fetal chromosome aberrations were different from the common aneuploidies and triploidy, whole genome analysis should be offered after invasive sampling. Because NIPT (as a second screening) has resulted in a decreased diagnostic yield it should be accompanied by an appropriate pre-test counselling in high risk pregnancies. Objectives: To examine whether combining the dichotomous assessment of the a-wave and the Ductus venosus (DV) PIV measurement improves first-trimester-screening performance. Methods: Retrospective study performed at the University Hospital of Tuebingen based on singleton pregnancies that underwent first-trimester-screening including DV flow assessment. In each case, the risk of Trisomy 21 was calculated based on maternal age, fetal NT, and DV flow either as dichotomous classification of the a-wave, as measurement of the DV PIV, or both. Results: There were 5280 euploid fetuses and 127 fetuses with Trisomy 21. The DV a-wave was reversed in 2.3% and 66.1% in the euploid and Trisomy 21 cases, respectively. The DV PIV measurements were above the 95th percentile in 8.3% and 77.2% the euploid and Trisomy 21 cases, respectively. For a FPR of 3%, DR for Trisomy 21 based on maternal age, fetal NT and DV flow is about 87% irrespective of whether DV is examined as a continuous or dichotomous variable. The combination of both resulted in a small decrease at 3% FPR. Conclusions: Assessment of the DV a-wave and the DV PIV result in similar DRs. Combining these two approaches does not appear to improve their individual screening performance.
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Screening for fetal aneuploidy and major abnormalities at 11-13 weeks' gestation, local particularities ''Gr.T.Popa'' Iasi, Iasi, Romania; 2 First Clinic, ''Cuza Voda'' Obstetrics Gynecology Hospital, Iasi, Romania Objectives: Chromosomal and structural anomalies screening at 11-13 weeks' gestation has grown rapidly in the last decade and now has an importance in prenatal consultation. To evaluate the results of this screening, according to local practice. Methods: Retrospective study of cases evaluated in 2009-2016. Were included in the study live, singleton pregnancies, with a Crown-rump length of 45-84 mm, which were evaluated for aneuploidy risk and major fetal abnormalities. Results: 1362 patients were evaluated, the majority (99.9%) being Caucasian. 21% of them had an age ≥35 years. 33 (2.4%) of cases had a nuchal translucency> 3.5 mm. beta-hCG and PAPPA screening was associated in 964 (70.7%) of cases. Nasal bone was present on 1223 (90%) and absent in 27 (2%) of cases. The flow on tricuspid valve was normal on 1290 (94%), regurgitation being present in 18 (1.3%) cases. Ductus venous had an average pulsatility index of 1.09 ± 0.17 (mean ± standard deviation). There were 91 invasive diagnostic manoeuvres, and of these, 70 (77%) were chorionic villus biopsy. In 24 of them (26%) of chromosomal abnormalities have been identified: 12 (50%) trisomies 21, 6 (25%) sex chromosome abnormalities, the remainder being triploidies and Trisomy 18. 39 fetuses 18 (2.8%) had different types of structural anomalies: acrania, holoprosencephaly, ventriculomegaly, cleft lip / palate,
